{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:21:07Z","timestamp":1788877267493,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-026786"],"award-info":[{"award-number":["MJFF-026786"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-026786"],"award-info":[{"award-number":["MJFF-026786"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Detection of alpha-synuclein (\u03b1-Syn) seeding activity in tear fluid (TF) offers a promising non-invasive biomarker for Parkinson\u2019s disease (PD). \u03b1-Syn seeding amplification assay (\u03b1SynSAA) detected seeding activity in 67% of PD-TF, while non-synucleinopathy samples remained negative. Electron microscopy of seeding-positive end products revealed fibrillar structures morphologically consistent with results of \u03b1SynSAA. \u03b1SynSAA effectively distinguished PD from controls and prion diseases based on seeding activity in TF.<\/jats:p>","DOI":"10.1038\/s41531-026-01282-2","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:25:00Z","timestamp":1771435500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Sezgi","family":"Canaslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Da Silva Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"van Riesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"1282_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nmeth1066","volume":"4","author":"R Atarashi","year":"2007","unstructured":"Atarashi, R. et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4, 645\u2013650 (2007).","journal-title":"Nat. Methods"},{"key":"1282_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mdc3.13710","volume":"10","author":"A Grossauer","year":"2023","unstructured":"Grossauer, A. et al. Alpha-Synuclein seed amplification assays in the diagnosis of synucleinopathies using cerebrospinal fluid\u2014a systematic review and meta-analysis. Mov. Disord. Clin. Pract. 10, 737\u2013747 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1282_CR3","doi-asserted-by":"publisher","first-page":"10783","DOI":"10.3390\/ijms251910783","volume":"25","author":"A Bougea","year":"2024","unstructured":"Bougea, A. Seeding aggregation assays in lewy bodies disorders: a narrative state-of-the-art review. Int J. Mol. Sci. 25, 10783 (2024).","journal-title":"Int J. Mol. Sci."},{"key":"1282_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo, A. et al. Detection of alpha-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 20, 203\u2013212 (2021).","journal-title":"Lancet Neurol."},{"key":"1282_CR5","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41591-023-02450-0","volume":"29","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist, S. et al. Cognitive effects of Lewy body pathology in clinically unimpaired individuals. Nat. Med 29, 1971\u20131978 (2023).","journal-title":"Nat. Med"},{"key":"1282_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","volume":"74","author":"M Bongianni","year":"2017","unstructured":"Bongianni, M. et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 74, 155\u2013162 (2017).","journal-title":"JAMA Neurol."},{"key":"1282_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.29246","volume":"38","author":"G Vivacqua","year":"2023","unstructured":"Vivacqua, G. et al. Salivary alpha-synuclein RT-QuIC correlates with disease severity in de novo Parkinson\u2019s disease. Mov. Disord. 38, 153\u2013155 (2023).","journal-title":"Mov. Disord."},{"key":"1282_CR8","doi-asserted-by":"crossref","unstructured":"Rastogi, S., Rani, K. & Kumar, S. Progression of cognitive impairment to Alzheimer\u2019s disease: through the lens of salivary extracellular vesicles. Neurosci. Insights 16, 26331055211058687 (2021).","DOI":"10.1177\/26331055211058687"},{"key":"1282_CR9","doi-asserted-by":"crossref","unstructured":"Dutta, S. et al. Alpha-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol. 142, 495\u2013511 (2021).","DOI":"10.1007\/s00401-021-02324-0"},{"key":"1282_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","volume":"18","author":"G Bellomo","year":"2023","unstructured":"Bellomo, G. et al. Cerebrospinal fluid lipoproteins inhibit alpha-synuclein aggregation by interacting with oligomeric species in seed amplification assays. Mol. Neurodegener. 18, 20 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1282_CR11","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","volume":"388","author":"M Schmitz","year":"2023","unstructured":"Schmitz, M. et al. Detection of prion protein seeding activity in tear fluids. N. Engl. J. Med. 388, 1816\u20131817 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1282_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65503-1","volume":"10","author":"F Maass","year":"2020","unstructured":"Maass, F. et al. Increased alpha-synuclein tear fluid levels in patients with Parkinson\u2019s disease. Sci. Rep. 10, 8507 (2020).","journal-title":"Sci. Rep."},{"key":"1282_CR13","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1002\/alz.14225","volume":"20","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette, A. et al. Associations between misfolded alpha-synuclein aggregates and Alzheimer\u2019s disease pathology in vivo. Alzheimers Dement. 20, 7624\u20137634 (2024).","journal-title":"Alzheimers Dement."},{"key":"1282_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70205","volume":"21","author":"EM Jonaitis","year":"2025","unstructured":"Jonaitis, E. M. et al. Misfolded alpha-synuclein co-occurrence with Alzheimer\u2019s disease proteinopathy. Alzheimers Dement. 21, e70205 (2025).","journal-title":"Alzheimers Dement."},{"key":"1282_CR15","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1002\/alz.14276","volume":"20","author":"D Tosun","year":"2024","unstructured":"Tosun, D. et al. Association of CSF alpha-synuclein seed amplification assay positivity with disease progression and cognitive decline: a longitudinal Alzheimer\u2019s Disease Neuroimaging Initiative study. Alzheimers Dement. 20, 8444\u20138460 (2024).","journal-title":"Alzheimers Dement."},{"key":"1282_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise, N. et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Ann. Neurol. 85, 691\u2013703 (2019).","journal-title":"Ann. Neurol."},{"key":"1282_CR17","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/diagnostics12040796","volume":"12","author":"L Giampietri","year":"2022","unstructured":"Giampietri, L. et al. Fluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative disorders: toward integrative diagnostic frameworks and tailored treatments. Diagnostics 12, 796 (2022).","journal-title":"Diagnostics"},{"key":"1282_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-023-00342-4","volume":"12","author":"M Schmitz","year":"2023","unstructured":"Schmitz, M. et al. Alpha-Synuclein conformers reveal link to clinical heterogeneity of alpha-synucleinopathies. Transl. Neurodegener. 12, 12 (2023).","journal-title":"Transl. Neurodegener."},{"key":"1282_CR19","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi, A. et al. Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies. Nat. Med. 29, 1448\u20131455 (2023).","journal-title":"Nat. Med."},{"key":"1282_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul, G. et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812\u2013818 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1282_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU Hoglinger","year":"2024","unstructured":"Hoglinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"1282_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1474-4422(24)00233-3","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. Concerns with the new biological research criteria for synucleinopathy\u2014Authors\u2019 reply. Lancet Neurol. 23, 663\u2013666 (2024).","journal-title":"Lancet Neurol."},{"key":"1282_CR23","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1212\/WNL.0000000000207147","volume":"100","author":"A Iranzo","year":"2023","unstructured":"Iranzo, A. et al. Misfolded alpha-synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder. Neurology 100, e1944\u2013e1954 (2023).","journal-title":"Neurology"},{"key":"1282_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(23)00371-X","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A., Concha-Marambio, L., Marek, K. & Soto, C. Alpha-synuclein seed amplification in Parkinson's disease-Authors' reply. Lancet Neurol. 22, 985\u2013986 (2023).","journal-title":"Lancet Neurol."},{"key":"1282_CR25","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1007\/s12035-018-1313-4","volume":"56","author":"M Schmitz","year":"2019","unstructured":"Schmitz, M. et al. Cerebrospinal fluid total and phosphorylated alpha-synuclein in patients with Creutzfeldt-Jakob disease and synucleinopathy. Mol. Neurobiol. 56, 3476\u20133483 (2019).","journal-title":"Mol. Neurobiol."},{"key":"1282_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra2119323","volume":"386","author":"I Zerr","year":"2022","unstructured":"Zerr, I. Laboratory diagnosis of Creutzfeldt-Jakob disease. N. Engl. J. Med. 386, 1345\u20131350 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1282_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1282_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman, B. R. et al. Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC. Acta Neuropathol. Commun. 6, 7 (2018).","journal-title":"Acta Neuropathol. Commun."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01282-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01282-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01282-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:22:27Z","timestamp":1773674547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01282-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01282-2","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}